0001209191-23-045479.txt : 20230811 0001209191-23-045479.hdr.sgml : 20230811 20230811172857 ACCESSION NUMBER: 0001209191-23-045479 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prout Samantha CENTRAL INDEX KEY: 0001743122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 231165319 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 FORMER NAME: FORMER CONFORMED NAME: Prout Samantha Whiteman DATE OF NAME CHANGE: 20180607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (215) 921-7600 MAIL ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC DATE OF NAME CHANGE: 20020729 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-09 0 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001743122 Prout Samantha C/O AMICUS THERAPEUTICS, INC. 3675 MARKET STREET PHILADELPHIA PA 19104 0 1 0 0 Chief Accounting Officer 1 Common Stock 2023-08-09 4 M 0 2376 10.04 A 139379 D Common Stock 2023-08-09 4 M 0 5040 9.55 A 144419 D Common Stock 2023-08-09 4 M 0 10592 10.03 A 155011 D Common Stock 2023-08-09 4 M 0 18901 12.11 A 173912 D Common Stock 2023-08-09 4 S 0 36909 14.0056 D 137003 D Stock Options (right to buy) 10.04 2023-08-09 4 M 0 2376 0.00 D 2029-01-02 Common Stock 2376 0 D Stock Options (right to buy) 9.55 2023-08-09 4 M 0 5040 0.00 D 2030-01-02 Common Stock 5040 2526 D Stock Options (right to buy) 10.03 2023-08-09 4 M 0 10592 0.00 D 2030-04-15 Common Stock 10592 3176 D Stock Options (right to buy) 12.11 2023-08-09 4 M 0 18901 0.00 D 2032-01-14 Common Stock 18901 37810 D This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.10 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. All of these options were fully vested and exercisable as of the transaction date. As of August 9, 2023, 5,985 options were fully vested and exercisable and 1,581 remained unvested from this individual 2020 grant. As of August 9, 2023, 11,164 options were fully vested and exercisable and 2,604 remained unvested from this individual 2020 grant. As of August 9, 2023, 22,444 options were fully vested and exercisable and 34,267 remained unvested from this individual 2022 grant. All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023. /s/ Christian Formica, Attorney-in-Fact 2023-08-11